ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
57 hedge funds and large institutions have $104M invested in Oncternal Therapeutics, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 16 increasing their positions, 8 reducing their positions, and 8 closing their positions.
Holders
57
Holders Change
+13
Holders Change %
+29.55%
% of All Funds
1.31%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
21
Increased
16
Reduced
8
Closed
8
Calls
$4K
Puts
–
Net Calls
+$4K
Net Calls Change
-$3K
Top Buyers
| 1 |
PA
1
Perceptive Advisors
New York
|
$23M |
| 2 |
2
BlackRock
New York
|
$5.97M |
| 3 |
3
Invesco
Atlanta,
Georgia
|
$2.78M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$6M |
| 5 |
5
State Street
Boston,
Massachusetts
|
$1.17M |
